Promising results from APDA-funded LRRK2 research

On July 25, 2018, the APDA Center for Advanced Research at the University of...see more Pittsburgh, led by the Centerโ€™s Director (and APDA Scientific Advisory Board member), Dr. J. Timothy Greenamyre, published results of a study highlighting the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinsonโ€™s disease.

Read More